T cell immunity and caregiving stress in young and older caregivers by Vitlic, Ana et al.
 
 
T cell immunity and caregiving stress in young and
older caregivers
Vitlic, Ana; Lord, Janet; Arlt, Wiebke; Oliver, Christopher; Whittaker, Anna
DOI:
10.12715/har.2015.4.15
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Vitlic, A, Lord, J, Arlt, W, Oliver, C & Phillips, A 2015, 'T cell immunity and caregiving stress in young and older
caregivers', Healthy Aging Research, vol. 4, 15. https://doi.org/10.12715/har.2015.4.15
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Article published under terms of Creative Commons attribution license.
Eligibility for repository checked February 2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
       Healthy Aging Research | www.har-journal.com   Vitlic et al. 2015 | 4:15 1 
 
T cell immunity and caregiving stress in young and older caregivers 
Ana Vitlic 1,2, Janet M. Lord 2,3, Wiebke Arlt 4, Christopher Oliver 5, Anna C. Phillips 1,2* 
1 School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, Birmingham, West Midlands, UK            
2 MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research, University of Birmingham, Edgbaston, Birmingham, West 
Midlands, UK 3 School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham, West Midlands, UK 4 Centre for 
Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Edgbaston, Birmingham, West Midlands, UK 5 School 
of Psychology, University of Birmingham, Edgbaston, Birmingham, West Midlands, UK 
Abstract 
Background: The present study aimed to examine the impact of caregiving stress and aging on parameters of T 
cell immunity using caregivers and controls across two age cohorts.  
Methods: Seventy-nine young and older caregivers (parents of children with developmental disabilities and 
spousal dementia caregivers, respectively) were compared to 76 non-caregiving controls. Participants completed 
questionnaires to provide information about socio-demographics, health behaviour, psychosocial and caregiving 
variables, and provided a blood sample. T cell senescence and exhaustion markers, thymic output, and serum 
CMV antibody titre were assessed.  
Results: Despite greater psychological morbidity (greater depression, anxiety, perceived stress) than controls, 
caregivers showed robust immunity for most T cell parameters with the exception of KLRG-1 (marker involved 
in T cell senescence pathway).  
Conclusions: A higher percentage of KLRG1+ T cells in caregivers could explain the poorer vaccination 
response that has previously been reported in this group. These data also suggest that the impact of caregiving 
per se on immunity is not uniform.  
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Introduction 
Chronic stress (e.g. that caused by caregiving or 
bereavement) has been reported to have numerous 
adverse effects on adaptive immunity [1]. The 
immune system correlates of the negative effects of 
stress include reduced vaccination response [2], 
poorer latent virus control [3] and thymic involution 
indicated by reduced output of naive T cells [4].  
Adaptive immunity undergoes dramatic changes 
during aging; this is termed immunosenescence and 
includes decreased naive T cell production [5] and a 
shift in numbers of naive T cells towards longer lived 
memory T cells – in particular CD8+ cells – as the 
memory T cell pool expands to maintain homeostasis 
[6]. Quantification of thymic output and naive T cell 
production is achieved by counting the number of 
cells expressing T cell receptor excision circles 
(TREC); stable extrachromosomal DNA fragments 
created during T cell receptor (TCR) formation [7].  
In addition, aging is accompanied by many 
phenotypic and functional alterations in T cell subsets. 
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For example, expression of CD28 antigen, a co-
stimulatory molecule necessary for T cell activation, 
is decreased during aging [8], with implications for 
longevity of vaccination responses and resistance to 
latent infections. Further, an increase in the subsets of 
senescent CD28-CD57+ lymphocytes with normal 
aging has been noted [9]. CD57 is present on 
terminally differentiated T lymphocytes; it is 
considered to be a marker contributing to T cell 
senescence [10] and is indicative of increased 
activation-induced apoptosis [11]. Programmed cell-
death-1 (PD-1), a receptor that plays an inhibitory role 
during T cell activation and is important in T cell 
exhaustion [12] is also present more frequently on 
aged T lymphocytes [13]. Finally, another inhibitory 
receptor commonly considered a marker of T cell 
senescence, is co-inhibitory cadherin killer-cell lectin-
like receptor G1 (KLRG-1) [14], which shows 
increased expression in older donors [15]. 
Interestingly, it has been shown that blockade of 
KLRG-1 leads to restoration of proliferative function 
by a mechanism involving the phosphorylation and 
activation of Akt protein kinase, suggesting KLRG-1 
regulates both exhaustion and senescence-related 
pathways [16]. Implications of these changes in cell 
senescence and cell exhaustion are a negative impact 
on the functional capacity of memory T cells, the 
integrity of the immune response overall, and thus 
resistance to infection [16].  
Another important contributor to immunosenescence 
is Cytomegalovirus (CMV) infection [17], a latent 
Herpes virus with the ability to remain silent until 
inflammatory factors and weakened immune 
surveillance trigger its activation. This virus is 
believed to direct the restructuring of lymphoid 
subsets in the periphery, seen as an increase in 
effector memory T cells and a reduction in the naive T 
cells in those who are CMV-seropositive [18]. 
Consequently, the presence of CMV leads to the 
accumulation of T cells with a senescent and 
exhausted profile, namely a CD28−CD57+KLRG-1+ 
phenotype. 
Until recently, there has been a consensus that 
caregivers, regardless of their age, have poorer 
immunity than non-caregivers [2, 19–22]. However, 
we have recently demonstrated that caregivers, both 
young and older, displayed robust neutrophil function 
compared to matched controls. Indeed, neutrophil 
function was only diminished in caregivers with 
higher psychological morbidity (unpublished data). 
The present analysis extends our previous 
observations with respect to innate immunity by 
examining the associations between caregiving stress, 
aging, and T cell immunity using four different 
participant groups: younger parental caregivers of 
children with developmental disabilities and age- and 
sex-matched parental controls of typically developing 
children; older spousal dementia caregivers, and 
matched healthy older adults. This four-group 
comparison allows us to examine the effects of 
caregiving stress on T cell immunity with and without 
aging.  
Focussing on T cell immunity, this study examined 
TREC expression as a marker of thymic output, and 
expression of markers of the senescent and exhaustion 
profiles of T cells. It also aimed to determine whether 
any psychosocial or caregiving-specific variables, e.g. 
depression, were related to greater immunosenescence 
within the caregiver group. It was expected that 
caregivers, particularly older caregivers, and those 
with higher psychological morbidity would show the 
greatest immunosenescence. Finally, by measuring 
anti-CMV antibody titre, the study aimed to ascertain 
if any group differences were driven by latent viral 
infection. 
 
Methods 
Participants  
Thirty-nine young parental caregivers and 34 age- and 
sex-matched control parents, and 40 older spousal 
caregivers and 42 matched controls were recruited. 
Inclusion criteria for the younger group were that they 
should have a child living at home aged between 3 
and 18 years. Our sample included parents of children 
with Smith–Magenis (28%), Fragile X syndrome 
(54%), and Cornelia de Lange (18%) syndromes; 
these were recruited via syndrome group events. 
Parents in the control group had typically developing 
children and were recruited via local advertisements. 
Older caregivers were aged 60+ years and full-time 
carers of a spouse/partner with diagnosed dementia; 
these participants were recruited via UK National 
Health Service (NHS) Trusts. Healthy participants in 
the older control group were recruited through the 
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Birmingham 1000 Elders group 
(http://www.birmingham.ac.uk/research/activity/mds/
centres/healthy-ageing/elders.aspx). 
Potential participants were excluded from any group if 
they were taking immunosuppressive drugs, had a 
chronic immune-related disease (e.g. cancer, diabetes, 
rheumatoid arthritis), or if they were pregnant.  
 
Study design and procedure 
This was a cross-sectional study, with a one-off 
session for the completion of the questionnaire and 
provision of a blood sample. Informed written consent 
was obtained from all participants, and the study was 
approved by the local NHS Research Ethics 
Committee. 
 
Questionnaires 
Health behaviours were assessed using a questionnaire 
adapted from the Whitehall II study [23]. The 
Hospital Anxiety and Depression Scale (HADS) [24], 
Perceived Stress Scale (PSS) [25], and Zarit Burden 
Interview (ZBI) [26], were used to determine 
psychological morbidity, while social support 
availability was examined using the Support Function 
Scale (SFS) [27]. Finally, children’s challenging 
behaviour was assessed through the Strengths and 
Difficulties Questionnaire (SDQ) [28], while the 
Pearlin Problematic Behaviour (PPB) [29] subscale 
was administered to older caregivers in order to report 
on the frequency of dementia-related behaviours in 
their spouse/partner. 
 
Blood sampling and assays 
Blood sampling 
Venous blood was collected into heparinised tubes, 
pre-prandially between 9 and 11 a.m. Peripheral blood 
mononuclear cells (PBMCs) were isolated by standard 
density gradient centrifugation using Ficoll-PaqueTM 
PLUS (GE Healthcare, Upsala Sweden), aliquoted and 
stored in a freezing medium of inactivated foetal calf 
serum (Sera Laboratories International, Sussex, UK) 
and 10% (v/v) dimethyl sulphoxide (DMSO), to allow 
recovery of functional frozen PBMCs.  
Immunostaining for senescent and exhausted profile 
of T cells 
Isolated PBMCs were stained with a combination of 
fluorochrome-conjugated anti-human antibodies and 
consequent multicolour flow cytometry analysis using 
a CyAnADPTM cytometer (Dako, Cambridgeshire, UK). 
Appropriate isotope controls were used to set the gates 
and compensation was conducted electronically (using 
Summit software) before each experiment using single 
stained cells. The specific anti-human antibodies used 
for staining can be obtained from the authors on 
request. Cells were washed and re-suspended in 
phosphate buffered saline with bovine serum albumin 
(PBS/BSA) for flow cytometry. At least 15,000 events 
were acquired within the lymphocyte gate for each 
sample. Further phenotyping was conducted on 
CD3+CD4+ and CD3+CD8+ cells. T cell senescent 
profiles were characterised by the absence of CD28 
and/or the presence of CD57, and the exhaustion 
profile was assessed by PD-1 expression, in CD4+ and 
CD8+ T-cells separately. KLRG-1+ T cells were 
separately examined, as they are involved in both 
senescence and exhaustion. Data analyses were 
conducted using Summit v4.3 software (Dako, USA) 
and are presented as the percentage of antigen-positive 
cells.  
 
Thymic output analysis 
Thymic output was assessed via T cell Receptor 
Excision Circles (TREC) analysis, where a low TREC 
expression ratio indicates lower thymic output of 
naive T-cells [30,31]. DNA was isolated from PBMCs 
using the QIAamp DNA Blood Mini Kit (Quiagen, 
UK) and eluted in 50µl of DNA elution buffer. DNA 
concentration and purity was subsequently measured 
using a NanoDrop™ spectrophotometer and only 
those samples with a 260/280 and 260/230 ratio above 
1.8 were used. Aliquots of 200ng of DNA were used 
for quantitative polymerase chain reaction (qPCR) 
analysis. Real-time PCR was performed on a Real 
Time PCR Roche LC480 sw1.5 machine using 
fluorescent primer- and probe-based chemistry 
(TaqMan probe). Reaction volume consisted of 
forward and reverse primers in a final concentration of 
0.5µM, and probes in a final concentration of 0.2µM 
for both TREC and the control gene, 2 x TaqMan 
Master Mix from LightCycler 480 Probes Master Mix 
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(Roche, UK) in a final reaction volume of 20µl per 
sample made using nuclease-free water (Roche, UK). 
The primer sequences for TREC were 5′-
CACATCCCTTTCAACCATGCT′ for forward, and 
5′-GCCAGCTGCAGGGTTTAGG-3′ for the reverse 
primer. 
ACACCTCTGGTTTTTGTAAAGGTGCCCACT 
was used as the fluorescent sequence-specific probe. 
Primers were dissolved in the quantity of provided 
buffer to yield 100pmol/µl, then aliquoted and stored 
at -20°C. For normalisation, a referent gene 
representing the constant region of the T cell receptor 
was used: 5'-CCTGATCCTCTTGTCCCACAG-3' for 
the forward primer, and 5'-
GGATTTAGAGTCTCTCAGCTGGTACA-3' for the 
reverse primer, as well as a 5'-
ATCCAGAACCCTGACCCTGCCG-3' probe. 
Samples were run in triplicate and an average Ct value 
was calculated for both TREC and the reference gene. 
Rather than calculating the exact number of copies of 
TREC per number of T cells for every sample, the 
Pfaffl formula [32] was used to quantify TREC by 
comparing TREC status to the calibrator. The lower 
the expression ratio, the higher the decrease of the 
TREC gene in the test sample when compared to the 
calibrator. 
 
CMV serum antibody titre 
A standardised CMV ELISA developed by the 
Antiviral Immunology Laboratory, Cancer Sciences, 
University of Birmingham was used as previously 
reported [33]. The standard curve measured up to 
1000 arbitrary units of IgG, and those with more than 
10 units were considered CMV-positive. 
 
Statistical analyses  
We aimed to recruit enough participants to detect a 
medium effect size (f=0.29). This required an overall 
sample size of 134, thus recruitment of 35 participants 
to each group. Where immune data were skewed, 
values were log-transformed. The main effects of age 
and caregiving status, as well as caregiving x age 
interactions, were examined using analysis of variance 
(ANOVA) tests, with partial η2 as the effect size. 
Demographic information, health behaviour variables, 
and numbers of CD3+ cells that were significantly 
different between the groups (in chi-square or 
ANOVA), were controlled for by analysis of co-
variance (ANCOVA) tests. Analyses were re-run 
using CMV status as a covariate to ascertain if any 
effects were driven by CMV infection. CMV 
seropositive participants were divided into two groups 
using a median split of anti-CMV antibody titre to 
examine associations with parameters of T cell 
immunity. Correlations were used within caregivers to 
test whether psychosocial and caregiving variables 
were associated with immune outcomes. 
 
Results 
Demographic information, health behaviour and 
psychosocial characteristics 
Descriptive statistics for demographic and health 
behaviour variables for each group are presented in 
Table 1. Caregivers and controls were comparable for 
all demographics and health behaviours, with the 
exception of young caregivers, who were more likely 
to be white and to drink alcohol daily compared to 
control parents. Older participants in the control 
groups tended to be more active than caregivers. Table 
1 shows that caregivers reported higher depression, 
anxiety, perceived stress, and lower social support 
than non-caregivers. Caregiving burden was also 
higher in younger caregivers than in controls, while 
older caregivers scored high on this scale according to 
the reported cut-off of 17 [26]. For problematic 
behaviour of care-recipients, younger parental 
caregivers reported more problems than control 
parents, while older spousal dementia caregivers 
reported higher scores on the Pearlin scale than those 
previously reported by caregivers [34]. 
 
Immunostaining for exhausted and senescent profile 
of T cells  
For CD3+ cell number (representative flow cytometry 
plot shown in Figure 1A), there was a main effect of 
caregiving (F(1,140)=7.97, p=0.005, η2=0.054), such 
that caregivers had higher numbers (Figure 1B). 
Therefore, CD3+ cell number was a covariate in 
subsequent analyses.  
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Table 1.  Demographic characteristics, health behaviours and psychosocial variables of each group 
 
 Young Older 
 Caregivers  
(n=39) 
Controls  
(n=34) 
 
 
Caregivers  
(n=40) 
Controls  
(n=42) 
 
 
 n (%)/Mean (SD) p N (%)/Mean (SD) p 
Age (years) 38.7 (4.78) 40.1 (5.44) 0.26 69.3 (5.81) 72.4 (5.42) 0.06 
Age of child/spouse (years) 7.6 (3.63) 7.2 (4.54) 0.66 72.3 (8.06) 73.1 (6.04) 0.63 
Gender (female) 25 (64) 21 (62) 0.84 26 (65) 19 (45) 0.07 
Marital status (partnered) 33 (89) 30 (88) 0.90 40 (100) 42 (100) - 
Ethnicity (Caucasian) 36 (97) 27 (79) 0.02 38 (97) 39 (93) 0.33 
Occupational status (non-manual) 30 (88) 31 (94) 0.41 22 (63) 32 (80) 0.10 
In full-time work  15 (48) 19 (63) 0.24 3 (8) 1 (4) 0.53 
No chronic illness  35 (95) 29 (85) 0.19 21 (55) 17 (42) 0.26 
Taking medications 2 (6) 7 (21) 0.06 33 (80) 29 (74) 0.51 
Alcohol intake (daily +) 10 (27) 1 (3) 0.01 10 (28) 12 (30) 0.83 
Smokers  (14) 2 (6) 0.30 1 (3) 3 (7) 0.36 
Hours of sleep (>7 hours) 6 (17) 3 (9) 0.38 7 (19) 8 (21) 0.86 
Body Mass Index  25.8 (4.65) 24.5 (3.58) 0.21 26.3 (3.08) 26.1 (4.37) 0.82 
Exercise score  5.2 (4.30) 6.4 (5.44) 0.29 3.5 (3.16) 5.2 (3.71) 0.04 
HADS anxiety score  10.4 (3.85) 6.4 (2.85) <0.001 7.7 (4.96) 4.1 (3.93) <0.001 
HADS depression score  8.5 (3.18) 4.2 (3.67) <0.001 6.0 (3.94) 2.8 (2.61) <0.001 
Perceived stress score  30.2 (5.68) 23.5 (6.59) <0.001 24.0 (8.21) 16.4 (7.83) <0.001 
Social support score (SFS)  31.6 (7.17) 38.6 (9.62) 0.001 33.6 (11.18) - - 
Caregiver burden score  26.0 (7.82) 13.7 (6.69) <0.001 21.0 (8.62) - - 
Child behaviour problems  19.6 (4.62) 7.2 (3.99) <0.001 - - - 
Pearlin problem behaviours - - - 22.9 (5.89) - - 
CMV seropositive 13 (34) 19 (59) 0.04 24 (63) 27 (64) 0.92 
CMV antibody titre  82.2 (178.75) 158.7 (223.34) 0.63 200.2 (261.08) 169.9 (190.07) 0.45 
 
 
Figure 1. CD3+ cell count 
 
A) Representative flow cytometry scatter plot of CD3+ cells. B) CD3+ cell count in old (n=35) and young (n=38) caregivers, and 
old (n=40) and young (n=31) controls. 
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Figure 2. CD3+ cells not expressing the CD28 marker 
 
Representative flow cytometric plots demonstrating the gating pattern used for identification of: A) CD4+CD28- and CD4+CD28+ 
cells within a CD3+ cell population of lymphocytes; B) CD8+CD28- and CD8+CD28+cells within a CD3+ cell population of 
lymphocytes. C) Absolute numbers of CD4+CD28- T cells in old (n=35) and young (n=38) caregivers, and old (n=40) and young 
(n=31) controls presented in 103/ml. D) Corresponding percentages of these cells in old (n=35) and young (n=38) caregivers, and 
old (n=40) and young (n=31) controls. E and F) Absolute numbers (presented in 103/ml) and percentage, respectively, of 
CD8+CD28- T cells in old (n=35) and young (n=38) caregivers, and old (n=40) and young (n=31) controls. Data are presented as 
mean, and standard error of the mean (SEM), rather than their log values used in the analyses. * indicates p<0.05.
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CD3+ T cells expressing/not expressing the CD28 co-
stimulatory molecule  
Figures 2A and B show representative flow cytometry 
plots demonstrating gating for identifying CD28-
positive and negative cells. There were no main 
effects of age or caregiving, or a caregiving x age 
interaction effect for CD4+CD28- T cell count (Figure 
2C). Subsequent analyses with covariate adjustment 
confirmed this. For the percentage of CD4+CD28- T 
cells, there were similarly no effects (Figure 2D).  
For CD8+CD28- T cell counts there was a main effect 
of age (F(1,140)=12.69, p=0.001, η2 =0.083) such that 
older participants had higher numbers of these cells, 
but no main effect of caregiving, nor interaction effect 
(Figure 2E). Covariate analyses confirmed the main 
effect of age (p<0.001), and revealed a main effect of 
caregiving, such that – unexpectedly – caregivers had 
lower numbers of these cells than controls (p=0.03). 
For CD8+CD28- T cell percentage there was a main 
effect of age (F(1,140)=22.94, p<0.001, η2=0.141) and 
caregiving (F(1,140)=5.27, p=0.02, η2=0.036) such 
that participants in the older group and controls had a 
higher percentage of CD8+CD28- cells. Pairwise 
comparisons revealed that the difference within the 
younger group was the main driver of the caregiving 
effect (see Figure 2F). Covariate analyses confirmed 
the main effects of age (p<0.001) and caregiving 
(p=0.02).  
For the numbers of CD3+ CD4+ cells expressing 
CD28, there was no main effect of age, but there was 
a main effect of caregiving (F(1,140)=11.55, p=0.001, 
η2=0.076) and a caregiving x age interaction effect 
(F(1,140)=4.63, p=0.03, η2=0.032) (see Figure 3A). 
However, covariate adjustment confirmed only the 
caregiving x age interaction effect (p=0.001), such 
that older caregivers had highest numbers. For the 
percentage of these cells, there were no significant 
effects (Figure 3B). 
For CD8+ CD28+ cell numbers, there was a main effect 
of age (F(1,140)=49.79, p<0.001, η2=0.262) and 
caregiving (F(1,140)=6.61, p=0.01, η2 =0.045), such 
that younger participants and caregivers had more of 
these cells, but no caregiving x age interaction (Figure 
3C). Covariate adjustment revealed only the main 
effect of age (p<0.001). For the percentage of these 
cells, again main effects of age (F(1,140)=35.35, 
p<0.001, η2=0.202) and caregiving (F(1,140)=10.68, 
p=0.001, η2=0.071 were observed, such that younger 
adults and caregivers had a higher percentage of these 
cells (Figure 3D). ANCOVA confirmed the effects of 
age and caregiving (p=0.001 and 0.03).  
 
CD3+ cells expressing the CD57 marker of T cell 
senescence  
For the CD4+CD57+ T cell count (flow cytometry 
identification shown in Figure 4A), there was a main 
effect of age (F(1,140)=11.86, p=0.001, η2=0.078) 
such that older adults had higher numbers (Figure 
4C); ANCOVA confirmed this (p=0.001). For the 
CD4+CD57+ T cell percentage, there was a main effect 
of age (F(1,140)=13.56, p<0.001, η2=0.088) and 
caregiving (F(1,140)=5.50, p=0.02, η2=0.038) such 
that older participants and controls had a higher 
frequency of CD4+CD57+ cells (Figure 4D). Covariate 
analyses confirmed only the main effect of age 
(p=0.003).  
For CD8+CD57+ T cell numbers (flow cytometry 
identification shown in Figure 4B), there was a main 
effect of age (F(1,140)=12.69, p=0.001, η2=0.083) 
such that participants from the older cohort had higher 
numbers of these cells, but no other significant effects. 
Covariate analyses confirmed the age effect, and 
revealed a main effect of caregiving (p=0.001 and 
0.03, respectively) (Figure 4E). For the percentage of 
these cells, there was a main effect of age 
(F(1,140)=38.70, p<0.001, η2=0.281) such that older 
participants had a higher percentage of CD8+CD57+ 
cells, confirmed after covariate adjustment (p<0.001), 
but there were no other significant effects (Figure 4F). 
 
KLRG-1+T cells 
For CD4+KLRG1+ T cell numbers (flow cytometry 
identification shown in Figure 5A), there was only a 
main effect of caregiving (F(1,140)=6.69, p=0.01, 
η2=0.047) such that caregivers overall had a higher 
percentage of cells expressing this marker (Figure 
5C); this was confirmed after covariate adjustment 
(p=0.04). There were no significant effects for the 
percentage of CD4+KLRG1+ T cells (Figure 5D), but 
after covariate adjustment a main effect of caregiving 
emerged (p=0.03) such that caregivers had a higher 
percentage of these cells.  
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Figure 3. CD3+ cells expressing the CD28 marker 
 
CD4+CD28+ T cells in old (n=35) and young (n=38) caregivers, and old (n=40) and young (n=31) controls presented in: A) absolute 
numbers (103/ml), and B) percentages. CD8+CD28- T cells in old (n=35) and young (n=38) caregivers, and old (n=40) and young (n=31) 
controls presented as: C) absolute numbers (103/ml), and D) percentages. Data are presented as mean and SEM. * indicates p<0.05 
 
 
For CD8+KLRG1+ T cell numbers (flow cytometry 
identification shown in Figure 5B), there was only a 
main effect of caregiving (F(1,140)=6.07, p=0.02, 
η2=0.042) such that caregivers overall had a higher 
numbers of these cells. After covariate adjustment, a 
main effect of age emerged (p=0.03) and the effect of 
caregiving was confirmed (p=0.04) (Figure 5E). For 
frequency of these cells, there was a main effect of 
age (F(1,140)=5.93, p=0.02, η2=0.041, and caregiving 
(F(1,140)=5.36, p=0.02, η2=0.037), with older adults 
and caregivers having a higher percentage, but no 
caregiving x age interaction effect (Figure 5F).  
Covariate adjustment confirmed these effects (p =0.01 
and 0.02).  
T cells expressing the PD-1 marker of exhaustion 
For CD4+PD1+ T cell count (flow cytometry 
identification shown in Figure 6A), there was a main 
effect of age (F(1,140)=16.01, p<0.001, η2=0.103) 
such that the older group had more of these cells, and 
a caregiving x age interaction effect (F(1,140)=6.30, 
p=0.01, η2=0.043) such that older caregivers had the 
highest number of these cells; covariate analyses 
confirmed these effects (p<0.001 and 0.04) (Figure 
6C). For the percentage, there was only a main effect 
of age (F(1,140)=22.45, p<0.001, η2=0.138) such that 
younger participants had a lower percentage of T cells 
expressing this marker of exhaustion (Figure 6D); 
covariate analysis confirmed this (p<0.001). 
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Figure 4. CD3+ cells expressing the CD57 marker of T cell senescence 
 
Representative flow cytometric plots demonstrating gating pattern for identification of: A) CD4+CD57+ cells within a CD3+ cell 
population of lymphocytes; and B) CD8+CD57+ cells within a CD3+ cell population of lymphocytes. CD4+ CD57+ T cells in old (n=35) 
and young (n=38) caregivers, and old (n=41) and young (n=31) controls, presented in: C) absolute numbers (103/ml), and D) percentages. 
E and F) present corresponding histograms for CD8+CD57+ T cells. Data are presented as mean and SEM. * indicates p<0.05. 
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Figure 5. CD3+ cells expressing the KLRG1 marker 
 
Representative flow cytometry describing gating method for detecting: A) CD4+KLRG1+ cells, and B) CD8+KLRG1+ within the 
population of CD3+ lymphocytes. CD4+KLRG1+ T cells in old (n=35) and young (n=38) caregivers, and old (n=40) and young (n=31) 
controls, presented in: C) absolute numbers (103/ml), and D) percentages. Under E and F are respective presentations of CD8+KLRG1+ 
T cells. Data are mean ± SEM. * indicates p<0.05 
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Figure 6. CD3+ cells expressing the PD-1 marker of exhaustion 
 
Percentage of T cells showing the expression of PD-1 marker of exhaustion. Representative flow cytometry plot showing gating strategy 
for detection of: A) CD4+PD-1+, and B) CD8+PD-1+ cells within a CD3+ lymphocyte subset. CD4+PD1+ T cells in old (n=35) and 
young (n=38) caregivers, and old (n=40) and young (n=31) controls, presented as: C) absolute numbers (103/ml), and D) percentages. E 
and F present corresponding values for CD8+PD-1+ T cells. Data are mean ± SEM. * indicates p<0.05 
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For the number of CD8+PD1+ T cells (flow cytometry 
identification shown in Figure 6A), there were no 
main or interaction effects, but after covariate 
adjustment a main effect of age emerged (p=0.02) 
(Figure 6E). For the frequency of these cells, there 
was a main effect of age (F(1,140)=17.72, p<0.001, 
η2=0.112) such that older adults had a higher 
percentage of T cells expressing this marker of 
exhaustion (Figure 6F). This was confirmed in 
covariate analyses (p<0.001). 
 
TREC levels 
There was a main effect of age on TREC levels 
(F(1,139)=109.82, p<0.001, η2=0.441) such that older 
participants had a greater fold decrease of cells 
containing TRECs when compared to the calibrator 
(Figure 7). Covariate adjustment confirmed the main 
effect of age (p<0.001). 
 
 
 
Figure 7. Thymic output presented as T cell receptor excision 
circles (TREC) expression ratio 
 
Log10 percentage of TREC expression ratio in old (n=35) and 
young (n=39) caregivers, and old (n=37) and young (n=32) 
controls. Data are mean ± SEM. * indicates p<0.05. 
 
CMV seropositivity and serum antibody titre 
Overall, 83 (55%) participants were CMV-positive, 
with more CMV-positive participants in the younger 
group (χ2(1)=4.91, p=0.03). In the younger group, 32 
(86%) were seropositive overall, with caregivers being 
less likely to be CMV-positive (χ2(1)=4.43, p=0.04). 
In the older group, 51 (64%) participants were CMV-
positive, and the incidence of CMV infection was 
similar between older caregivers and controls 
(χ2(1)=0.01, p=0.92). Within the CMV-positive subset 
(n=82) for CMV antibody titre, there was no main 
effect of age, caregiving, or a caregiving x age 
interaction.  
Analyses of T cell subsets expressing markers of 
senescence and exhaustion were re-run, this time 
controlling for CMV serostatus, to determine if any of 
the effects observed were driven by CMV infection. 
All significant main effects of age remained the same, 
while the caregiving effect for CD8+CD28- (p=0.20), 
CD8+CD28+ (p=0.17), as well as CD8+CD57+ 
(p=0.20), disappeared. However, the main effect of 
caregiving for T cells expressing KLRG1 remained 
significant for both CD4+ (p=0.01) and CD8+ (p=0.02) 
T cells. 
Finally, median CMV titre was used to split CMV-
seropositive subjects into two groups, with high vs. 
low serological responses indicating worse or better 
viral control. The comparison of T cell immunity 
parameters between the groups are presented in Table 
2. Interestingly, the groups were significantly different 
on almost all immune parameters. 
 
Psychological factors and immune parameters 
within caregivers in each group 
Within the caregiving group overall, analyses showed 
that caregivers reporting higher anxiety, depression 
and stress levels had a lower percentage of CD57+ for 
both CD4+ and CD8+, and CD4+PD-1+ T cells, as well 
as a higher expression ratio of TREC (Table 3). In 
addition, those with a higher burden index had a lower 
percentage of CD4+ T cells expressing the PD-1 
marker of exhaustion, as well as higher TREC 
expression (Table 3).  
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Table 2.  T cell immunity parameters between CMV-seropositive 
participants with high and low CMV titre, created using median 
split of CMV titre 
 
 High CMV 
 titre 
Low CMV 
 titre 
 
 Mean (SD) p 
CD3+CD4+CD28- cell 
number#  
1.3 (1.23) 1.1 (0.73)  0.07 
CD3+CD4+CD28- 
cells % 
13.5 (12.52) 6.1 (7.39) <0.001 
CD3+CD8+CD28- cell 
number 
2.5 (1.56) 1.0 (0.76) <0.001 
CD3+CD8+CD28- 
cells (%) 
57.6 (18.39) 35.9 (18.23) <0.001 
CD3+CD4+CD28+ 
cell number 
6.2 (2.67) 7.7 (2.52)  0.001 
CD3+CD4+CD28+ 
cells (%) 
80.1 (15.56) 88.3 (8.04) 0.001 
CD3+CD8+CD28+ 
cell number 
1.9 (1.37) 2.1 (1.2) 0.12 
CD3+CD8+CD28+ 
cells (%) 
42.3 (19.07) 61.5 (17.26) <0.001 
CD3+CD4+CD57+ 
cell number 
1.0 (0.71) 0.5 (0.47) <0.001 
CD3+CD4+CD57+ 
cells (%) 
15.8 (12.11) 6.5 (6.48) <0.001 
CD3+CD8+CD57+ 
cell number 
2.5 (1.56) 1.0 (0.76) <0.001 
CD3+CD8+CD57+ 
cells (%) 
53.5 (20.76) 29.9 (18.00) <0.001 
CD3+CD4+KLRG1+ 
cell number 
0.6 (0.59) 0.5 (0.83) 0.01 
CD3+CD4+KLRG1+ 
cells (%) 
8.5 (8.61) 5.7 (9.95) <0.001 
CD3+CD8+KLRG1+ 
cell number 
1.0 (1.14) 0.6 (0.56) 0.03 
CD3+CD8+KLRG1+ 
cells (%) 
23.5 (21.59) 18.4 (16.12) 0.43 
CD3+CD4+PD1+ cell 
number 
1.2 (0.81) 0.9 (0.39) 0.01 
CD3+CD4+PD1+ cells 
(%) 
16.1 (9.51) 10.3 (5.17) <0.001 
CD3+CD8+PD1+ cell 
number 
1.0 (0.72) 0.8 (0.43) 0.25 
CD3+CD8+PD1+ cells 
(%) 
20.0 (11.27) 21.9 (9.4) 0.10 
TREC expression 
ratio 
0.3 (0.34) 0.4 (.41) 0.03 
# cell number is expressed as number x 103/ml 
 
  
 
Table 3.  Correlations between T cell immunity and caregivers' 
psychosocial characteristics 
 
 Caregivers overall (n=73) 
 
 CD4+CD57+  
(%) 
 
CD8+CD57+  
(%) 
CD4+PD-
1+ 
 (%) 
TREC 
 
Anxiety 
 
-0.25 
p=0.04 
 
ns 
 
-0.24 
p=0.05 
 
0.31 
p=0.01 
 
Depression 
 
-0.26 
p=0.03 
 
-0.24 
p=0.04 
 
-0.30 
p=0.01 
 
0.38 
p=0.001 
 
Perceived 
stress 
 
-0.30 
p=0.01 
 
-0.31 
p=0.01 
 
-0.35 
p=0.003 
 
0.35 
p=0.003 
 
Caregiver 
burden  
 
ns 
 
ns 
 
-0.25 
p=0.03 
 
0.32 
p=0.01 
ns = non-significant  
 
Analysis of the caregiving participants in the younger 
group showed that young caregivers reporting higher 
depression, anxiety, perceived stress and burden 
levels, as well as more problematic behaviour in their 
child(ren), had higher TREC expression (Table 4). In 
the older group, caregivers reporting higher 
problematic behaviour in their spouses/partners had a 
higher percentage of CD8+CD57+ T cells (Table 4). 
 
 
Table 4.  Correlations between T cell immunity and young/old 
caregivers' psychosocial characteristics 
 
 Young  
(n=38) 
Old 
(n=35) 
 TREC CD8+CD57+ 
   
Anxiety -0.34 p=0.04 ns 
Depression -0.53 p=0.001 ns 
Perceived stress -0.52 p=0.001 ns 
Caregiver burden  0.44 p=0.01 ns 
Child behaviour 
problems (SDQ) 
0.35 p=0.03 - 
Pearlin problematic 
behaviour 
- 0.42 p=0.02 
ns = non-significant  
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Discussion 
In the present study we have shown an age-related 
increase in the absolute number and frequency of the 
CD8+CD28- subset, but caregivers unexpectedly 
showed lower numbers of these cells than age- and 
sex-matched controls, with younger caregivers also 
having a lower frequency of these cells than younger 
controls. CD8+CD28+ T cells predictably showed age-
related changes in the opposite direction, and a 
caregiving effect in favour of caregivers. While age-
related differences were in agreement with previous 
reports [8], the apparent positive effect of caregiving 
was unexpected. The negative impact of CD28-CD8 T 
cells on immunity is related to their loss of 
proliferative capacity and a resulting decreased 
tolerance [35]. The high percentages of CMV- and 
EBV-specific CD8+CD28- T cells in older adults [36] 
are also thought to compromise immunity by 
occupying immunological space, leaving limited room 
for other T cell subsets to expand when new 
pathogens are encountered 17]. Accumulation of 
CD28- T cells with age has been attributed to repeated 
antigen stimulation, as T cell activation induces 
decreases in CD28 expression through lifelong 
exposure to pathogens and the constant stimulation by 
chronic viral infections such as CMV [37]. The 
present findings confirmed significantly higher 
numbers of these cells in those with higher CMV 
antibody titres, but caregivers had a lower incidence 
of CMV. Therefore, a possible explanation for the 
lower levels of CD8+CD28- T cells in young 
caregivers is the significantly lower incidence of 
chronic CMV infection when compared to the young 
controls, which would reduce the overall infectious 
burden responsible for expansion of the CD8+CD28- T 
cell subset [36]. Additional confirmation for this was 
gained in the repeated analyses using CMV status as 
covariate, where the caregiving effect disappeared but 
age remained significant.  
As previously reported, in both the CD4+ and CD8+ 
subset of T cells, CD57+ cells were more abundant in 
the older sample, and this has been related to limited 
proliferative capacity [10]. On the other hand, the 
preserved T cell profile in the case of CD8+CD57+ 
cells, and lower percentages of CD4+CD57+ cells 
shown among older caregivers was unexpected. 
However, in the elderly, increased CD57+ cells have 
previously been related to CMV infection [38]. 
Although in the present study there was no difference 
between older caregivers and controls in terms of 
serum CMV antibody titre, the percentage of 
CD4+CD57+ T cells was significantly positively 
correlated with levels of anti-CMV antibodies (data 
not shown), which could explain the unexpected 
increase in the percentage of these cells amongst older 
controls. This is further confirmed by the significantly 
higher numbers of these cells among those with a 
relatively higher CMV antibody titre, and analyses 
adjusting for CMV status eliminated the caregiving 
effect. On the other hand, the increase in CD57+ cells 
in both CD4+ and CD8+ subsets, although more 
prominent in the latter, has been shown to occur after 
acute exercise, which mobilised these terminally 
differentiated, highly cytotoxic cells in both young 
and old [39]. Thus, perhaps the low percentages of 
these cells in caregivers in the current sample are a 
dampening of the numbers of cells with high killing 
potential due to the chronic stress of caregiving. 
Finally, it has been argued that cells expressing CD57 
and/or lacking CD28 represent only terminally 
differentiated effector T cells with high cytotoxic 
potential. These then apoptose after activation, and are 
therefore not markers of immune deficiency [40]. 
KLRG-1 was increasingly expressed on CD8+ T cells 
from the older participants in this study, confirming 
previous findings [41]. This is not surprising, as this 
marker of terminally differentiated T cells is 
associated with replicative senescence and inhibits 
cell proliferation [41]. In addition, KLRG-1 is known 
to down-regulate CD95-mediated cell lysis and, in 
certain cases, inhibit T cell activation [42]. 
Interestingly, blockade of this inhibitory marker can 
restore proliferative function, which indicates the 
potential involvement of KLRG-1 in exhaustion-
related pathways [41]. Compared to controls, KLRG-1 
was also increasingly expressed on both CD4+ and 
CD8+ T cells in caregivers, indicating that chronic 
caregiving stress can affect the functionality of T cell 
immunity. This higher percentage of functionally 
impaired T cells rich in inhibitory receptors such as 
KLRG-1 may explain the poorer vaccination response 
observed in caregivers [19, 21, 22]. It is known that 
KLRG-1 prevents the response of CD4+ T cells to 
novel antigens [43] necessary for achieving adequate 
immune protection following vaccination. Further, 
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epigenetic studies lend support for this target-specific 
effect of caregiving stress on those T cells expressing 
this senescence marker in caregivers, regardless of 
their age. Stress through epigenetic changes can 
impact on immune-related genes via HPA-axis effects 
[44]. A study of post-traumatic stress disorder showed 
changes in DNA methylation profiles and gene 
expression, including KLRG-1, potentially 
compromising the immunity of stressed individuals 
[44]. 
Consistent with most previous research [45], 
significant age effects were observed for both 
CD4+PD-1+ and CD8+PD-1+ T cells, with older adults 
having a higher percentage of both of these subsets. 
Chronic caregiving stress did not appear to affect PD-
1 expression, as caregivers in the current sample 
showed an exhaustion profile comparable to the 
controls. Therefore, it seems that although physical 
stress, such as laparoscopic surgery, can induce an 
increase in PD-1 expression on T lymphocytes [46], 
caregiving stress may not affect this aspect of 
immunity.  
The significant age effect on TREC expression was in 
agreement with previous research, indicating a 
decrease in thymic output and production of naive T 
cells with aging [47]. However, no negative effect of 
caregiving stress was observed; if anything, caregivers 
showed a trend towards higher thymic output than 
controls, largely influenced by the younger group.  
It was not expected that a higher percentage of CMV-
positive individuals would be found in the younger 
group; the number is higher than previously reported 
for an equivalent age group [48]. However, since 
children’s CMV infection rates can be high due to 
day-care centre attendance, this observation could be 
due to specifically targeting parents [49]. 
Interestingly, comparison between CMV-seropositive 
participants with high and low serological profiles 
revealed group differences in almost all T cell 
immunity parameters. This agrees with previous data, 
which suggest that CMV drives T cells towards 
senesced or exhausted profiles through repeated 
stimulation in an attempt to control the infection [50]. 
Higher psychological morbidity was related to lower 
levels of some immunosenescence markers and higher 
TREC. This seems counterintuitive, but the overall 
effect may result from the higher psychological 
morbidity scores in the group of younger caregivers, 
who, due to their age, also exhibit the expected lower 
or absent immunosenescence shown in terms of T cell 
marker expression and output of naïve T cells. This is 
further confirmed by the direct relationship between 
higher problem behaviours in care-recipients and a 
higher percentage of CD8+CD57+ T cells among the 
older caregivers, and suggests that – for older 
caregivers at least – future research into caregiving 
stress should focus on those with higher psychological 
morbidity. 
Overall, these results provide a mixed picture of the 
effect of caregiving stress on T cell phenotype in the 
young and old, with the KLRG1 marker of cell 
senescence being the main responder to caregiving 
stress. These data also indicate that the contribution of 
caregiving stress to immunosenescence is not uniform 
across T cell functional markers. The KLRG1 result 
may indicate that a prominent negative effect of 
caregiving stress in both young and old would be seen 
during an active, in vivo immune 
stimulation/challenge the adaptive immune system, 
such as vaccination [22]. Caregiving stress in these 
situations may prevent the immune system from 
mounting an adequate response. Thus, the higher 
percentage of KLRG1- T cells in caregivers and 
controls presents a potential mechanism for the poorer 
vaccination responses previously reported in 
caregivers [43]. 
This study has a number of limitations. First, the 
sample size is somewhat small, but it is of the same 
magnitude as in previous caregiving studies, and large 
enough to determine the medium effect sizes reported 
in previous studies. Second, one could argue that 
participation in the study biased the sample towards 
those caregivers with lower overall burden and stress 
levels, and therefore with better immunity. However, 
attempts were made to avoid this bias by providing 
home visits for participants. Further, scores on 
psychosocial scales were comparable if not higher 
than those in previous research, suggesting that our 
caregivers did indeed have high burden and stress 
levels. Finally, staining frozen and thawed PBMCs 
might have given different results to fresh PBMCs, 
but as all the samples were treated in the same way, 
from the moment of blood sampling until data 
acquisition on the flow cytometer, effects would have 
been standardised across all groups.  
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In conclusion, caregivers showed poorer KLRG-1 T 
cell profiles compared to controls, but negative effects 
of caregiving, or an interaction between aging and 
caregiving stress, were not seen for other markers of T 
cell-related immunosenescence and exhaustion. This 
KLRG-1 effect could explain previous caregiving 
effects on vaccination response, and suggests KLRG-
1 as a target for future interventions. Further, among 
older caregivers, those who reported higher 
behavioural problems in care recipients showed a 
greater senescence profile. These findings underline 
the importance of considering individual differences 
in the impact of caregiving stress on immunity, and 
that future research should focus on those reporting 
higher psychological morbidity.  
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